R-2HG Targets FTO to Increase m6A Levels and Suppress Tumor Growth
- PMID: 29269348
- DOI: 10.1158/2159-8290.CD-RW2017-240
R-2HG Targets FTO to Increase m6A Levels and Suppress Tumor Growth
Abstract
R-2HG, thought to be an oncometabolite in IDH-mutant tumors, has antitumor activity in leukemia and glioma.
©2018 American Association for Cancer Research.
Comment on
-
R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling.Cell. 2018 Jan 11;172(1-2):90-105.e23. doi: 10.1016/j.cell.2017.11.031. Epub 2017 Dec 14. Cell. 2018. PMID: 29249359 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
